Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$1.85B |
| 2 |
Burlington
BURL
|
+$1.01B |
| 3 |
Philip Morris
PM
|
+$781M |
| 4 |
JPMorgan Chase
JPM
|
+$679M |
| 5 |
General Motors
GM
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.71B |
| 2 |
Netflix
NFLX
|
+$1.61B |
| 3 |
Illumina
ILMN
|
+$1.2B |
| 4 |
Mercado Libre
MELI
|
+$1.12B |
| 5 |
Amazon
AMZN
|
+$976M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 19.04% |
| 3 | Communication Services | 14.79% |
| 4 | Consumer Discretionary | 12.62% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Target
TGT
$69.9B
| $235M | 0.07% |
1,492,473
+345,466
| +30% | +$47.4M |
|
202
Xcel Energy
XEL
$49.1B
| $233M | 0.07% |
3,371,604
-33
| -0% | -$2.25K |
|
|
DFS
203
DELISTED
Discover Financial Services
DFS
| $231M | 0.07% |
3,997,560
+1,451,014
| +57% | +$76M |
|
204
AT&T
T
$166B
| $227M | 0.07% |
10,544,999
+3,608
| +0% | +$80.6K |
|
205
Madrigal Pharmaceuticals
MDGL
$12.4B
| $224M | 0.07% |
1,885,327
+188,208
| +11% | +$20.4M |
|
206
Guardant Health
GH
$22.2B
| $223M | 0.07% |
1,992,670
+39,650
| +2% | +$3.63M |
|
|
SIVB
207
DELISTED
SVB Financial Group
SIVB
| $221M | 0.07% |
916,717
+93
| +0% | +$21.9K |
|
208
Prologis
PLD
$134B
| $216M | 0.06% |
2,145,878
-669
| -0% | -$67K |
|
209
Zoom
ZM
$30.8B
| $215M | 0.06% |
458,027
-495,811
| -52% | -$159M |
|
210
Intuit
INTU
$91.6B
| $214M | 0.06% |
655,056
-212
| -0% | -$66.3K |
|
211
Teck Resources
TECK
$32.4B
| $213M | 0.06% |
15,320,606
-1,109
| -0% | -$13.1K |
|
212
Paycom
PAYC
$9.52B
| $211M | 0.06% |
678,687
+77,771
| +13% | +$22.7M |
|
213
Cisco
CSCO
$488B
| $210M | 0.06% |
5,335,269
+3,243,118
| +155% | +$141M |
|
214
Enbridge
ENB
$112B
| $204M | 0.06% |
6,986,851
+1,910
| +0% | +$60.1K |
|
215
Bank of Montreal
BMO
$129B
| $203M | 0.06% |
3,467,693
-2,784,728
| -45% | -$161M |
|
216
Five Below
FIVE
$13.2B
| $200M | 0.06% |
1,573,290
+529,888
| +51% | +$60.3M |
|
217
Equity Residential
EQR
$24.2B
| $198M | 0.06% |
3,855,199
+1,065,459
| +38% | +$58.9M |
|
218
RELX
RELX
$60.2B
| $194M | 0.06% |
8,671,486
+4,796,627
| +124% | +$108M |
|
|
219
Illumina
ILMN
$29.1B
| $191M | 0.06% |
634,354
-3,488,599
| -85% | -$1.2B |
|
220
Progressive
PGR
$121B
| $190M | 0.06% |
2,003,855
+31
| +0% | +$2.79K |
|
221
GSK
GSK
$101B
| $188M | 0.06% |
3,995,003
+291,087
| +8% | +$14.6M |
|
222
Yeti Holdings
YETI
$3.85B
| $186M | 0.06% |
4,093,142
| – | – |
|
223
Copart
CPRT
$26.8B
| $181M | 0.05% |
6,890,340
+3,218,740
| +88% | +$78M |
|
224
New York Times
NYT
$10.3B
| $175M | 0.05% |
4,092,344
-62,308
| -1% | -$2.73M |
|
225
Lockheed Martin
LMT
$140B
| $175M | 0.05% |
455,772
-955,468
| -68% | -$365M |
|
Similar funds
Capital Research Global Investors's Q3 2020 Portfolio in Review
As of Q3 2020, Capital Research Global Investors held 426 positions worth $333B, up 5.4% from $316B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Research Global Investors's Q3 2020 filing shows 27 new, 161 increased, 170 reduced and 21 closed positions. Its largest new stake was Penumbra: 1,572,825 shares worth $306M. The largest sale was Meta Platforms (Facebook), an estimated $2.71B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q3 2020 buy was Penumbra: 1,572,825 shares worth $306M.
- Capital Research Global Investors added most to Comcast in Q3 2020, an estimated $1.85B increase.
- Capital Research Global Investors's biggest Q3 2020 reduction was Meta Platforms (Facebook), cutting an estimated $2.71B.
- Capital Research Global Investors fully exited Simon Property Group in Q3 2020, selling an estimated $245M.
- Capital Research Global Investors's ten largest holdings make up 34% of its $333B portfolio in Q3 2020.
- Capital Research Global Investors opened 27 new positions and closed 21 in Q3 2020.
- Capital Research Global Investors's portfolio value rose 5.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.